The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A clinical study of tremelimumab alone or in combination with olaparib in patients with advanced epithelial ovarian cancer.
 
Stephanie Gaillard
Consulting or Advisory Role - AstraZeneca; Immunogen; Rigel (Inst); Sermonix Pharmaceuticals
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Genentech/Roche (Inst); Iovance Biotherapeutics (Inst); Pfizer (Inst); PharmaMar (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - Sermonix Pharmaceuticals
 
Maureen Berg
No Relationships to Disclose
 
Jeanne Harrison
No Relationships to Disclose
 
Peng Huang
No Relationships to Disclose
 
James M. Leatherman
No Relationships to Disclose
 
Michele Doucet
No Relationships to Disclose
 
Rupashree Sen
Research Funding - Bristol-Myers Squibb (Inst); Compugen (Inst)
Patents, Royalties, Other Intellectual Property - Compugen (I)
 
Aditya Suru
Employment - Nayam Innovations
 
Hongyan Cai
No Relationships to Disclose
 
Jennifer N. Durham
Employment - AstraZeneca/MedImmune (I)
Stock and Other Ownership Interests - AstraZeneca/MedImmune (I)
 
Danijela Jelovac
No Relationships to Disclose
 
Ashley Cimino-Mathews
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst)
 
Sudipto Ganguly
Research Funding - Bristol-Myers Squibb (Inst); Compugen (Inst)
Patents, Royalties, Other Intellectual Property - Compugen (Inst)
 
Leisha A. Emens
Leadership - Society for Immunotherapy of Cancer
Stock and Other Ownership Interests - Molecuvax
Consulting or Advisory Role - Abbvie; Bayer; Bristol-Myers Squibb; Chugai Pharma; etheRNA; Genentech/Roche; Gritstone Bio; Lilly; Macrogenics; Medimmune; Molecuvax; Novartis; Peregrine Pharmaceuticals; Replimune; Silverback Therapeutics; Syndax
Research Funding - Aduro Biotech; AstraZeneca; Corvus Pharmaceuticals; EMD Serono; Genentech; Maxcyte; Merck; Roche; Tempest Therapeutics
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genentech; Roche
Other Relationship - Aduro Biotech